Quarterly Activities/Appendix 4C Cash Flow Report
Arovella Therapeutics reports strong financials and key milestones for Q4 FY24.
Arovella Therapeutics
iNKT Cell Therapy
Cancer Treatment
Stock Market News
Biotechnology
Posted on: 24/07/2024
Read More